This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (3299) Participatory Medicine & E-Patients (773) Precision Medicine (75) Patient-Reported Outcome Measures (PROMs) (288) Chronic Conditions (270) Instruments and Questionnaires for Nutrition and Food Intake (166) E-Health / Health Services Research and New Models of Care (517)

Published on in Vol 23, No 12 (2021): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/30291, first published .
Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial

Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial

Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial

Authors of this article:

Dorit Vedel Ankersen1 Author Orcid Image ;   Petra Weimers1 Author Orcid Image ;   Mette Bennedsen1 Author Orcid Image ;   Anne Birgitte Haaber2 Author Orcid Image ;   Eva Lund Fjordside1 Author Orcid Image ;   Moritz Emanuel Beber3 Author Orcid Image ;   Christian Lieven3 Author Orcid Image ;   Sanaz Saboori1 Author Orcid Image ;   Nicolai Vad1 Author Orcid Image ;   Terje Rannem1 Author Orcid Image ;   Dorte Marker1 Author Orcid Image ;   Kristine Paridaens4 Author Orcid Image ;   Suzanne Frahm1 Author Orcid Image ;   Lisbeth Jensen5 Author Orcid Image ;   Malte Rosager Hansen1 Author Orcid Image ;   Johan Burisch1 Author Orcid Image ;   Pia Munkholm1 Author Orcid Image
Article Authors Cited by (17) Tweetations (15) Metrics

Journals

  1. Wang X, Wang B. Editorial: Highlights in abdominal and pelvic pain 2021/2022. Frontiers in Pain Research 2023;4 View
  2. Russo F, Riezzo G, Orlando A, Linsalata M, D’Attoma B, Prospero L, Ignazzi A, Giannelli G. A Comparison of the Low-FODMAPs Diet and a Tritordeum-Based Diet on the Gastrointestinal Symptom Profile of Patients Suffering from Irritable Bowel Syndrome-Diarrhea Variant (IBS-D): A Randomized Controlled Trial. Nutrients 2022;14(8):1544 View
  3. Whelan K, Staudacher H. Low FODMAP diet in irritable bowel syndrome: a review of recent clinical trials and meta-analyses. Current Opinion in Clinical Nutrition & Metabolic Care 2022 View
  4. Ng Q, Yau C, Yaow C, Chong R, Chong N, Teoh S, Lim Y, Soh A, Ng W, Thumboo J. What Has Longitudinal ‘Omics’ Studies Taught Us about Irritable Bowel Syndrome? A Systematic Review. Metabolites 2023;13(4):484 View
  5. Zhao X, Shi L, Ning B, Zhao Z, Li X, Zhu M, Zhang Y, Fu J. Efficacy of diet restriction with or without probiotic for treatment of patients with IBS‐D: Phase I−II clinical trial. Immunity, Inflammation and Disease 2023;11(5) View
  6. Morariu I, Avasilcai L, Vieriu M, Lupu V, Morariu B, Lupu A, Morariu P, Pop O, Starcea I, Trandafir L. Effects of a Low-FODMAP Diet on Irritable Bowel Syndrome in Both Children and Adults—A Narrative Review. Nutrients 2023;15(10):2295 View
  7. Lomer M. The low FODMAP diet in clinical practice: where are we and what are the long-term considerations?. Proceedings of the Nutrition Society 2023:1 View
  8. Larson D, Henning J, Burgermaster M. Smartphone Applications (Apps) for Nutrition Education: A Qualitative Analysis of Outpatient Dietitian Perspectives. Journal of Nutrition Education and Behavior 2023;55(8):596 View
  9. Gazizova Y, Bakirkhanov D, Nefedova T, Kostikova N, Akhmedzyanova D, Tashchyan O, Shumskaya Y, Mnatsakanyan M. Evaluation of the effectiveness of telemedical technologies in patients with digestive diseases. Digital Diagnostics 2023;4(1S):22 View
  10. Colgan A, Digby K, Apekey T, Elborough‐Whitehouse I, Seamark L, Radcliffe O, Williams M, Hickson M. A dietitian‐led low‐FODMAP diet webinar: a pre–post study evaluating its impact on symptoms of irritable bowel syndrome. Journal of Human Nutrition and Dietetics 2024;37(2):396 View
  11. Yan M, Man S, Sun B, Ma L, Guo L, Huang L, Gao W. Gut liver brain axis in diseases: the implications for therapeutic interventions. Signal Transduction and Targeted Therapy 2023;8(1) View
  12. Tayama J, Hamaguchi T, Koizumi K, Yamamura R, Okubo R, Kawahara J, Inoue K, Takeoka A, Fukudo S. Efficacy of an eHealth self-management program in reducing irritable bowel syndrome symptom severity: a randomized controlled trial. Scientific Reports 2024;14(1) View
  13. Conley T, Parkes M, Moss S, Probert C. Assessing ‘response’ to the low-FODMAP diet in irritable bowel syndrome: Should we be reporting harder primary endpoints?. Clinical Nutrition 2024;43(5):1079 View
  14. Babikow L, Fawcett T, Pfeifer E, Berry S. Integrated Virtual Care for Irritable Bowel Syndrome. Gastroenterology Nursing 2024;47(2):85 View
  15. Berentsen B, Thuen C, Hillestad E, Steinsvik E, Hausken T, Hatlebakk J. The Effects of Digital eHealth versus Onsite 2-day Group-based Education: A Comparison of Two Cohorts of 255 Patients with Irritable Bowel Syndrome (Preprint). JMIR Human Factors 2022 View
  16. Lopes C, de Jesus Monteiro C, Duarte A, dos Santos J. Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome—A Narrative Review. Journal of Clinical Medicine 2024;13(21):6337 View
  17. Foulkes R, Shah P, Twomey A, Dami L, Jones D, Lomer M. A service evaluation of FODMAP restriction, FODMAP reintroduction and long‐term follow‐up in the dietary management of irritable bowel syndrome. Journal of Human Nutrition and Dietetics 2024 View